Lipodystrophy and Fat Metabolism During Exercise (FAT)

University of Exeter

Status: Withdrawn

Conditions: Healthy; Lipodystrophy, Familial Partial

Treatments: Behavioral: 60-minutes of steady state exercise; Dietary Supplement: High-carbohdyrate breakfast; Dietary Supplement: Caffeine

Study type: Interventional

Funder types: Other

Identifiers

NCT04056000

258840

Details and patient eligibility

About

Mandibular dysplasia with deafness and progeroid features (MDP) syndrome is a rare genetic metabolic disorder that causes lipodystrophy: the inability of the body to store subcutaneous adipose tissue (fat under the skin). This creates a unique scenario where any ingested fat is diverted to the abdomen and liver, often leading to diabetes.

The investigators have an opportunity to study an individual with MDP who has competed in and won national para-cycling championships and is able to prevent/control his diabetes by regular bicycle training. He has approached us for advice on nutritional strategies to improve his cycling performance, and insight into how he uses fat during exercise.

The investigators also wish to study a moderately-trained cyclist with Familial partial lipodystrophy (FPL). Those with FPL show a different pattern of lipodystrophy than those with MDP, allowing us to further increase the investigator's understanding of fat utilisation in those with lipodystrophy during exercise.

The investigators know how subcutaneous fat is used during exercise, and how duration, nutrition, carbohydrate availability, and exercise intensity can affect this. The investigators aim to investigate these processes during exercise in MDP and FPL. This will potentially provide nutrition and performance advice to the individuals, and insight on fat use in lipodystrophy and diabetes.

Full description

During prolonged sub-maximal endurance exercise, both fat and carbohydrate are readily used substrates. The relative contribution and regulation of either is dependent on substrate availability (endogenous and exogenous), the duration of exercise, and the intensity of exercise. For example, exercising under fasted or caffeine supplemented conditions increases adipose tissue lipolysis, free fatty acid availability, and thus fat utilisation, whilst exercising under fed or carbohydrate loaded conditions increases glucose availability from elevated liver and muscle glycogen stores, and thus carbohydrate utilisation. This is important during prolonged sub-maximal exercise because when the limited endogenous carbohydrate stores are depleted, the body must rely more on fat. However, it is not known whether this regulation is present in conditions such as MDP and FPL where there is essentially no adipose tissue.

The investigators have an opportunity to study an individual with MDP who has competed in and won national para-cycling championships. He has approached us for advice on nutritional strategies to improve his cycling performance, and insight into how he uses fat during exercise. Intriguingly, the individual has provided anecdotal evidence that exercising under fasted conditions severely impairs his performance but that the use of caffeine improves his performance. He also states that he uses carbohydrate feeding strategies before and during prolonged exercise but is unsure whether it helps or not. This raises two fundamental questions that should be answered before any nutritional advice should be given (e.g. should a pre-exercise fat feeding or low glycemic index carbohydrate strategy be adopted?):

1. Do fasting and caffeine stimulate lipolysis in lipodystrophy and, if so, where is the fat coming from?
2. Does carbohydrate feeding before exercise impair lipolysis in lipodystrophy?

In order to answer these questions, the investigators need to directly measure rates of fat and carbohydrate utilisation from the circulation and muscle stores during exercise in the individual and a control participant using a stable isotope infusion approach. As well as providing results of significant scientific interest to the lipodystrophy field (researchers, clinicians, patients) and answering fundamental exercise physiology questions on substrate availability, the investigators hope that the outcomes will offer a substantial platform for improving the participant's knowledge of exercise nutrition and exercise performance.

Sex: Male

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

SUBJECT WITH FPL

Inclusion:

• Already known to researchers. Male, 29 years old.

CONTROL SUBJECT 1

Inclusion:

• Highly trained, elite-level cyclist (VO2max > 80 ml/kg/min)
• Registered with, and racing under the jurisdiction of, British Cycling
• ~< 10% of body fat
• Male
• 18 - 35 years old

Exclusion:

• Any diagnosed metabolic impairment, as this may affect normal metabolism.
• Any diagnosed cardiovascular disease or hypertension to avoid any complications associated with heavy exercise.
• Chronic use of any prescribed or over-the-counter pharmaceuticals.

CONTROL SUBJECT 2

Inclusion:

• Recreationally active, preferably with experience of cycling training.
• Similar (± 5 ml⋅kg-1⋅min-1) VO2max¬ to that of the participant with MDP

Exclusion:

• Any diagnosed metabolic impairment, as this may affect normal metabolism.
• Any diagnosed cardiovascular disease or hypertension to avoid any complications associated with heavy exercise.
• Chronic use of any prescribed or over-the-counter pharmaceuticals.

SUBJECT WITH FPL

Inclusion:

• Recreationally active, preferably with experience of cycling training.
• Similar (± 5 ml⋅kg-1⋅min-1) VO2max¬ to that of the participant with MDP
• Diagnosis with FPL

Exclusion:

• Female
• Any diagnosed cardiovascular disease or hypertension to avoid any complications associated with heavy exercise.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

0 participants in 3 patient groups

Exercising following the ingestion of a high-carbohydrate br

Experimental group

Description:

60 minutes of cycling, with the ingestion of a high-carbohydrate breakfast and 200 mg of caffeine.

Treatment:

Dietary Supplement: Caffeine

Behavioral: 60-minutes of steady state exercise

Dietary Supplement: High-carbohdyrate breakfast

Exercising following the ingestion of caffeine only

Experimental group

Description:

60 minutes of cycling, with the ingestion of 200 mg of caffeine.

Treatment:

Dietary Supplement: Caffeine

Behavioral: 60-minutes of steady state exercise

Exercising in the absence of breakfast or caffeine ingestion

Experimental group

Description:

60 minutes of cycling, without the ingestion of breakfast, or caffeine.

Treatment:

Behavioral: 60-minutes of steady state exercise